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Abstract: Many detection methods for phycotoxins, bioactive compounds produced by harmful
algae, focus on one compound or a class of related compounds. Multiple harmful algal species
often co-occur in the environment, however, emphasizing the need to analyze for the presence of
multiple groups of marine and freshwater phycotoxins in environmental samples, e.g., extracts
from solid phase adsorption toxin tracking (SPATT). Two methods were developed to screen for 13
phycotoxins (microcystin-RR, -LR, -YR, azaspiracid-1, -2, karlotoxin 3, goniodomin A, brevetoxin-2,
yessotoxin, pectenotoxin-2, dinophysistoxin-1, -2, and okadaic acid) in organic SPATT extracts using
ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS) equipped
with a trapping dimension (trap) and at-column dilution (ACD). The performance of each compound
under 36 combinations of chromatographic conditions was characterized, and two final methods,
acidic and basic, were selected based on peak shapes, signal intensities, resolution, and the separation
in time of positive and negative MS ionization modes. Injection volumes of up to 1 mL were possible
through trap/ACD technology, resulting in limits of detection between 0.001 and 0.05 µg/L across the
analytes. Benefits highlighted in this study, beyond the improved detection limits and co-detection of
multiple toxin groups, include the ability to inject samples of 100% organic solvent, ensuring analyte
stability and streamlining workflow through the elimination of laborious sample preparation steps.
Keywords: phycotoxins; mass spectrometry; UPLC-MS/MS; at-column dilution; SPATT; microcystins;
okadaic acid; azaspiracids; pectenotoxins; brevetoxins
Key Contribution: Two methods were developed for the analysis of 13 phycotoxins in organic SPATT
extracts that eliminated the need for concentration, dry-down, and reconstitution steps, reducing time
and labor required in sample preparation. The optimized methods proved successful as a screening
tool for all 13 phycotoxins in SPATT extract from the lower Chesapeake Bay.
1. Introduction
Bioactive compounds produced by various species of harmful algae, or phycotoxins, have the
potential to cause both mass mortalities of wildlife [1,2] and severe illnesses in humans [2,3]. Animals
that ingest algae associated with phycotoxins may experience direct health effects and/or mortality,
or they may serve as vectors of exposure to other organisms when consumed (Table 1) [3,4]. Human
exposure can occur through the consumption of contaminated seafood [3] or drinking water [5], or
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through respiration of aerosolized compounds [6]. Due to their hazardous effects, phycotoxins are
monitored in edible tissue, drinking water, and the environment.
While robust and sensitive mass spectrometry methods have been incorporated into some
monitoring programs, these methods are often developed for a single group of compounds, especially
in regions where annual blooms of the same species occur. The global expansion in range and frequency
of harmful algal blooms [7–9], however, emphasizes the need for multi-toxin detection methods for
co-occurring harmful algae. Research regarding the presence of co-occurring harmful algal species
and/or their associated phycotoxins has recently expanded, and such co-occurrences have now been
documented globally [10–16]. Some algal species can co-produce multiple phycotoxins (Table 1),
further adding to the suite of compounds that may be present in a given environmental sample.
Additionally, the salinity gradient in estuaries and along coastal zones, such as Chesapeake Bay and its
Eastern Shore, presents an increased probability for the co-occurrence of phycotoxins associated with
marine and freshwater species [4,16,17].
A limited number of LC-MS methods for the co-detection and quantification of marine and
freshwater phycotoxins have been published [18–21]. We sought, however, to develop a multi-toxin
screening method for Chesapeake Bay’s unique suite of toxins observed across the salinity gradient
(Table 1), streamline workflow, and improve method performance required for their trace analysis.
Ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS)
equipped with a trapping dimension (trap) and at-column dilution (ACD) (Figure 1) was investigated.
Applying trap/ACD to UPLC-MS/MS allows for large volume injections (50–1000 µL) of extracts
in 100% organic solvent [22]. This technology, therefore, has the potential to facilitate trace level
analysis by improving detection limits, removes the need for dry-down and concentration steps,
streamlining sample preparation [22], and minimizes lipophilic phycotoxin degradation or sorption
loss that would otherwise occur in more typical aqueous extracts. As the intention is to later pair this
novel screening method with SPATT, a common passive sampling tool that accumulates phycotoxins
over deployment [11,23–27], a developed method also requires evaluation using SPATT samples. By
applying UPLC-MS/MS with trap/ACD to SPATT organic extracts we expect to combine the benefits of
low detection limits with cumulative sorption in the environment, respectively.
Figure 1. Schematic of a UPLC-MS/MS system equipped with a trapping dimension (trap) and
at-column dilution (ACD).
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Table 1. Summary [2,28,29] of 13 phycotoxins included in the development of a UPLC-MS/MS
screening method
Phycotoxin Congener
Abbreviation (Group) Producer Human Syndrome or Toxicity
GDA (goniodomins) Alexandrium monilatum Ichthyotoxic
OA; DTX1; DTX2 (okadaic acid
and dinophysistoxins) Dinophysis spp., Prorocentrum lima
Diarrhetic shellfish poisoning
(DSP)
PTX2 (pectenotoxins *) Dinophysis spp. Acute toxicity in vertebrate modelwith i.p. injection
YTX (yessotoxin *)
Protoceratium reticulatum,
Gymnodinium catenatum,
Pyrodinium bahamense, Gonyaulax
spp.
Lingulodinium polyedrum
Acute toxicity in vertebrate model
with i.p. injection
AZA-1; AZA-2 (azaspiracids) Amphidoma languida, Azadiniumspp.
Azaspiracid shellfish poisoning
(AZP)
KmTx 3 (karlotoxins) Karlodinium spp. Ichthyotoxic
MC-LR; MC-YR; MC-RR
(microcystins)
Microcystis spp., Anabaena spp.,
Oscillatoria spp.
Planktothrix spp.
Hepatotoxic
PbTx-2 (brevetoxins) Karenia spp. Neurotoxic shellfish poisoning(NSP), ichthyotoxic
* Indicates a toxin group that is regulated in seafood products in the EU, but not in the US.
The overarching goal of this study, therefore, was to develop a screening tool for the detection of
multiple marine and freshwater phycotoxins in SPATT samples collected from Chesapeake Bay. This
study also aimed to conduct a comprehensive investigation of phycotoxin behavior under a variety
of column and mobile phase chemistries. Phycotoxins included in this study (Table 1) were chosen
to represent toxins (1) spanning a range of hydrophobicities from highly lipophilic (PbTx-2) to more
polar (KmTx 3, microcystins), (2) federally regulated in marine seafood products or freshwater systems
(i.e., OA, DTXs, microcystins), (3) of emerging national interest (AZAs), and/or (4) associated with
animal illness within the local Chesapeake Bay (i.e., karlotoxins, goniodomin A). All variants within
each phycotoxin group were not included in this study; instead, selection amongst congeners focused
on parent structures or congeners most commonly detected in U.S. waters. For field-sample analysis,
SPATTs deployed in the Chesapeake Bay region were extracted and analyzed for endogenous toxins
and matrix effects using the finalized methods.
2. Results and Discussion
The selected marine and freshwater phycotoxins, ranging in hydrophobicity, mode of toxicity,
and molecular weight (Table 1), were assessed for their performance under multiple combinations
of chromatographic conditions in the development of a screening tool for Chesapeake Bay. The 13
diverse compounds were successfully co-detected in the same organic extract using two optimized
final methods, one using acidic loading, diluting, and mobile phase solutions, and another using
basic loading, diluting, and mobile phase solutions, with a C18 trap and analytical column. Method
development was conducted using 50 µL injections of mixed toxins in 100% organic solvent to allow
for the co-detection of trace compounds, improve analyte stability, and streamline workflow. The
optimized method was then applied to 1000 µL injections as a proof-of-concept, demonstrating that
the method could perform under circumstances where further-improved detection was required. The
injection of elevated volumes, 50–1000 µL, of organic solution directly onto the UPLC-MS/MS system
was possible via the trap/ACD technology. These final methods may be further adapted to include
additional compounds of interest and other types of environmental samples beyond SPATTs.
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2.1. Chromatographic Method Development
The performance of the 13 selected compounds in 36 combinations of trapping columns, analytical
columns, and mobile phases was evaluated and characterized during method development (Figure 2).
Overall, the C18 analytical column produced higher signal intensities than the C8 analytical column
under acidic conditions, and signal intensities were comparable under basic conditions (data not
shown). The C18 analytical column was, therefore, chosen for both methods with the added benefit
that no changing of columns was needed between subsequent runs. The performance of C18 and Oasis
Direct Connect trapping columns were superior to C8 in most cases (Figure 2). Coupling low loading
pH with high eluting pH, or vice versa, produced poor peak shapes and relatively low signal intensities
for many compounds evaluated. MC-RR, MC-LR, and MC-YR performed well under both basic
and acidic conditions, but exhibited the highest sensitivity using basic conditions. AZA1 and AZA2
were best detected under acidic conditions and produced broad peaks under basic conditions. Under
acidic conditions, a small peak with the same confirmatory MRM transition as PTX2 was detected
at a retention time of 7.17 min, shortly after the peak for PTX2 at 6.76 min, while only one peak at
6.76 min was present for PTX2 under basic conditions. This agrees with published results about the
epimerization of PTX2 under acidic conditions [30]. YTX was undetectable under acidic conditions but
performed well under basic conditions. PbTx-2 and GDA produced better peak shapes and signal
intensities under basic conditions than acidic conditions. DTX2 was detectable and exhibited good
peak shape under almost all tested conditions, but had the greatest sensitivity using basic conditions.
OA and DTX1 behaved similarly, with best peak shape and sensitivity observed under basic conditions.
KmTx 3 exhibited the best sensitivity under basic conditions, but produced acceptable peak shape and
sensitivity under acidic conditions with the C18 and Oasis trapping columns.
Table 2. Chromatographic conditions for the two final UPLC inlet methods: acidic and basic
Analyte Trapping Column LoadingConditions
Separation
Column
Elution
Conditions
MC-LR
MC-YR
MC-RR
AZA1
AZA2
KmTx 3
XBridge
BEH C18
130 Å
10 µm,
2.1 × 30 mm
H2O + 50 mM
formic acid + 2 mM
ammonium
formate
Isocratic for 3 min
Acquity
BEH C18
130 Å
1.7 µm,
2.1 × 50 mm
Acidic
A: H2O + 50 mM
formic acid + 2 mM
ammonium
formate
B: ACN + 50 mM
formic acid + 2 mM
ammonium
formate
Linear gradient 5%
to 95% B over 5 min
Isocratic 95% B for
1 min
GDA
PTX2PbTx-2YTXOA
DTX1
DTX2
XBridge
BEH C18
130 Å
10 µm,
2.1 × 30 mm
H2O + 6.7 mM
NH4OH
Isocratic for 3 min
Acquity
BEH C18
130 Å
1.7 µm,
2.1 × 50 mm
Basic
A: H2O + 6.7 mM
NH4OH
B: ACN + 6.7 mM
NH4OH
Linear gradient 5%
to 95% B over 5 min
Isocratic 95% B for
1 min
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Figure 2. Method development results showing the performance of 13 phycotoxins in 18 of the 36 trialed combinations of chromatographic conditions using a C18
analytical column. Loading phases were varied between acidic (formic acid), neutral (no additive), and basic (ammonium hydroxide); elution mobile phases were
varied between acidic (formic acid) and basic (ammonium hydroxide), and C8, C18, and Oasis HLB Direct Connect HP trap columns were tested. Loading phases
contained ultrapure water with 5% additive, while elution mobile phases contained (A) ultrapure water and (B) acetonitrile with 0.5% additive. Green boxes represent
uniform, gaussian peak shape. Yellow boxes represent poor peak shape (sh: shoulder, br: broad, lead: leading, tail: tailing, MP: multiple peaks, split: split peak). Red
boxes represent no detection. Numbers represent peak height. These results were used to devise the final methods listed in Table 2, which include modifications to
methods 2 and 17.
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Two methods, an acidic and a basic, were necessary for the detection of all 13 compounds evaluated.
Although some compounds performed well in multiple combinations of chromatographic conditions,
Method 2 (acidic conditions) and Method 17 (basic conditions) were chosen as the best methods to
optimize based on each compound’s peak shape and signal intensity, resolution between adjacent
peaks, and the separation in time of positive and negative ionization modes (Figure 2). Retention time
windows were used to eliminate loss in sensitivity from rapid switching between ESI+ and ESI− [31].
The range of retention times for compounds evaluated in ESI− (OA, DTX1, DTX2, YTX), therefore,
had to be separated from the rest of the compounds. To satisfy this condition, MC-RR, -YR, and -LR
were analyzed under acidic conditions even though they exhibited higher sensitivity when using basic
conditions (Figure 2). This compromise ensured a retention time window for OA, DTX1, DTX2, and
YTX that did not overlap with any positively ionizing compounds. When using the basic method, the
mass spectrometer operates in ESI− from 3–6.20 min, and in ESI+ from 6.20–8 min. All compounds
included in the acidic method were detected using ESI+.
2.2. Final Chromatography Methods
Once the compounds were designated to their acidic or basic method during development
(Figure 2), steps were taken to further optimize the chromatographic conditions to achieve two
final methods (Table 2). The compositions of the loading and mobile phases were refined from
developmental methods by varying the amount (strength) of additive and by adding ammonium
formate as a buffer to the acidic loading, diluting, and mobile phases. Overall, higher-strength additive
loading (5%) and mobile (0.5%) phases (Figure 2) were adequate for the detection of all compounds
tested. Lower-strength additive solutions, however, were selected for method optimization as they
produced the highest sensitivity and eliminated shifts in retention time between injections. Final acidic
loading and mobile phase solutions contained 50 mM (0.2%) FA + 2 mM ammonium formate, and final
basic loading and mobile phases solutions contained 6.7 mM (0.1%) ammonium hydroxide (Table 2).
Using the two final methods, carryover and other performance metrics were evaluated, and
field-sample analysis was conducted (see Sections 2.4 and 2.5); ultimately all compounds were well
resolved and exhibited acceptable peak shape and signal intensity (Figure 3).
2.3. Reduction of Carryover
Upon the first attempt at evaluating the performance of the final methods (Table 2), carryover
between samples resulted in high %RSD values (up to 26%) as peak areas for each compound increased
during triplicate 50 µL injections from the same vial. To reduce carryover, however, a wash step was
introduced into the method, and was applied to all instrumental components up to, but not including,
the analytical column: i.e., the injection and trapping circuits are washed with the solution. A wash
solution containing acetonitrile, methanol, isopropyl alcohol, and acetone (1:1:1:1) + 5% formic acid
was applied through the chromatographic inlet method at a flow rate of 2 mL/min in 2 min intervals,
alternating with the aqueous loading phase. While the mobile phase gradient ran through the trapping
and analytical columns between 3 and 8 min, the wash intervals ran through the flow-through needle
injection loop and associated circuit, being sent to waste before reaching the trapping column. At
9 min, the wash intervals extended into the trapping column and were sent to waste without reaching
the analytical column. The addition of these wash steps reduced carryover from 18.6% to <4%, and
extended the run time from 10 to 16 min, producing a suitable wash step to move forward as part of
the final two methods.
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Figure 3. Chromatograms obtained from a 50 µL mixed-toxin standard run of the final, optimized
methods under (A) acidic conditions, and (B) basic conditions.
2.4. Method Performance Characteristics
To evaluate method performance characteristics, acidic and basic methods were performed
sequentially. All acidic injections were run first, followed by all basic injections. Three blank injections
using the basic method were included after the last acidic injection and before the first basic injection
to equilibrate the instrument to basic conditions.
Once carryover was addressed, linearity and percent relative standard deviation (%RSD) were
evaluated and determined acceptable for the final two methods (Table 3). More specifically, two
10-point standard curves, across multiple orders of magnitude, were produced in triplicate for each
compound to assess linearity across multiple orders of magnitude. One standard curve ranged from
the closest concentration to each LOD (Table 3) through 5 µg/L, and the other from 5 µg/L through
50 µg/L. Linear regressions were performed on each curve, and all curves were linear within the tested
range with squared correlation coefficients (R2) values > 0.99. Similarly, to determine repeatability,
percent relative standard deviation (%RSD) was used to compare peak areas obtained from replicate
injections of the same mixed-standard solution. All %RSD values were below 5%, with the exception
of PbTx-2 at 7.18% (Table 3). These results indicate that the final methods are reproducible for all
13 phycotoxins.
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Limits of detection (LOD) and quantitation (LOQ) were determined for high-volume injections:
50 and 1000 µL (Table 3). Using standard solutions, LODs generated with 50-µL injections were, in
general, on par with previously-reported LODs using traditional UPLC-MS/MS methods, with the
exception of microcystins for which improved LODs have been reported (Table 3). By further increasing
the injection volume to 1000 µL, lower limits of detection (LOD) were achieved for all 13 phycotoxins,
surpassing published LODs for traditional UPLC-MS/MS analysis (Table 3). All experimentally-derived
LODs (S/N ≥ 3) were confirmed using triplicate injections of a mixed-standard solution at the LOD
concentration, and/or through their comparison to mathematically-derived LODs (Table 3). In contrast
to some literature methods, the methods reported herein did not require the addition of a concentration
step, e.g., solid-phase extraction (SPE), evaporation to dryness, or the use of a high-resolution mass
spectrometer to achieve improved detection limits (Table 3).
Together these results suggest that high-volume injections, up to 1000 µL, may be used to improve
detection of analytes in field samples. Higher injection volumes are only recommended when trace
analysis is needed, however, as instrument fouling can occur more rapidly when injecting these high
volumes. Blank injections included after 1000 µL injections confirmed the lack of additional carryover
due to the increased injection volume. We also note that repeatability was not sacrificed with high
injection volumes, as %RSD values for both the 50 µL and 1 mL injections were within acceptable
limits (Table 3).
This application highlights the benefits of UPLC-MS/MS with trap/ACD technology. Sample
preparation time and labor were reduced, and evaporative loss was eliminated as 100% organic
extracts were analyzed directly without additional clean-up or concentration and reconstitution steps.
The reported low detection limits will be useful in exploring the prevalence of trace phycotoxin
concentrations present in the Bay. This technology is not limited to phycotoxins, and application for
other groups of compounds typically analyzed by LC-MS is possible.
2.5. SPATT Analysis
Triplicate SPATTs deployed at three sites in the Chesapeake Bay region were extracted using
traditional methods [23], and 50 µL of organic extract was analyzed by the two final, optimized
analytical methods (Table 2). In every SPATT extract that was analyzed, endogenous OA, DTX1, and
PTX2 were detected (Figure 4). The amount of endogenous toxins in SPATT extracts were similar
whether calculated using parent > parent or parent > daughter transitions (Table 4). SPATT extracts
from the York River had the highest levels of each of these phycotoxins, while SPATT extracts from
Wachapreague had the lowest. Across sites, OA (8.6–25 ng OA/g resin/day) was highest relative to
DTX1 (0.06–4.4 ng DTX1/g resin/day) and PTX2 (0.4–2.9 ng PTX2/g resin/day). The positive detection of
these phycotoxins confirms that this method is suitable for use as a screening tool for SPATT extracts.
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Table 3. Results for the method performance characteristics of repeatability and limits of method detection and quantification using final two methods: acidic and
basic. Limits of detection found in the literature from other studies using various LC-MS methods are presented for comparison.
Literature This Study
Analyte
LOD
LC-MS
Methods
(µg/L)
Reference
LOQ
(S/N ≥ 10)
50 µL
(µg/L)
LOD
(S/N ≥ 3)
50 µL
(µg/L)
%RSD
50 µL
LOD Calc.
50 µL
(µg/L)
LOD Calc.
50 µL
(pg on-
column)
%RSD
1000 µL
LOD Calc.
1000 µL
(µg/L)
LOD Calc.
1000 µL
(pg on-
column)
MC-RR 0.017 ˆ [32] 0.31 0.13 3.81 0.07 3.5 3.66 0.007 7.5
MC-YR 0.043 ˆ [32] 0.15 0.13 3.23 0.24 12 7.32 0.01 15
MC-LR 0.029 ˆ [32] 0.15 0.13 3.10 0.25 13 5.80 0.01 12
AZA1 0.033 [33] 004 0.03 3.02 0.02 1.0 2.12 0.001 1.0
AZA2 0.070 [34] 0.04 0.03 2.56 0.01 0.5 3.11 0.001 1.5
GDA 2.34 [35] 1.98 0.60 2.43 0.39 19.5 2.45 0.019 19.2
KmTx3 4.0 * [36] 1.39 0.97 5.64 0.64 32 5.64 0.05 54
OA 0.483 [33] 0.15 0.13 1.21 0.10 5.0 4.05 0.008 8.3
DTX1 0.030 [34] 0.15 0.13 2.30 0.11 5.5 5.87 0.01 12
DTX2 0.930 [20] 1.24 0.13 1.43 0.12 6.0 3.05 0.006 6.2
PTX2 0.048 [33] 0.04 0.03 1.89 0.04 2.0 3.91 0.004 3.7
YTX 0.336 [33] 1.24 0.50 1.19 0.14 7.0 4.27 0.03 34
PbTx-2 n.r. 0.15 0.13 7.18 0.16 8.0 7.39 0.03 15
ˆ Indicates when reported detection limit includes SPE concentration step, * indicates when reported on-column detection limit was converted to µg/L, S/N signal to noise ratio, %RSD
percent relative standard deviation, LOQ limit of quantification, LOD limit of detection, calc. mathematically derived from six repeated injections, n.r. none reported.
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Figure 4. Endogenous OA, PTX2, and DTX1 in SPATT extracts from three sites in the lower Chesapeake
Bay region using 50-µL injections under the final two methods: acidic and basic. Data were generated
using the parent > parent transitions and are represented as ng toxin per gram SPATT resin per day,
and error bars represent standard deviation from triplicate field samples.
Table 4. Concentrations of endogenous phycotoxins in Chesapeake Bay SPATT extracts determined
using the parent > parent transition (P > P) and the parent > daughter transition (P > D) for each
compound. The final optimized methods were utilized with a 50 µL injection volume.
York Nassawadox Wachapreague
P > P
(µg/L)
P > D
(µg/L)
P > P
(µg/L)
P > D
(µg/L)
P > P
(µg/L)
P > D
(µg/L)
OA 34 ± 2.4 27 ± 2.3 21 ± 0.4 17 ± 0.3 13 ± 1.7 11 ± 1.2
PTX2 3.9 ± 0.7 3.5 ± 0.6 2.1 ± 0.04 1.9 ± 0.6 0.6 ± 0.1 0.6 ± 0.1
DTX1 6.1 ± 0.7 6.1 ± 0.7 2.8 ± 0.1 2.9 ± 0.2 1.0 ± 0.2 1.0 ± 0.2
Furthermore, when these SPATT extracts were spiked with a multi-toxin solution, all 13 toxins
were detectable with S/N > 3 for the parent > parent transitions, showing that the final methods are
suitable as a screening tool across the diverse suite of marine and freshwater toxins in Chesapeake
Bay and the complex matrix associated with SPATTs. Varying levels of signal enhancement and signal
suppression, however, were observed for each compound (Table 5), suggesting that targeted cleanup,
matrix-matched standard curves, or the standard addition method should be considered in studies with
more quantitative objectives. Signal suppression or enhancement was calculated by comparing spiked
samples to a standard solution using the equation Suppression or Enhancement (%) = 100 × spiked extract
peak area/spiked standard peak area. Signal suppression was observed for MC-RR, -LR, and -YR, AZA1,
and AZA2. YTX showed signal enhancement in Nassawadox and Wachapreague extracts. Because
OA, DTX1, and PTX2 were already present in the SPATT extracts from all three sites, matrix effects for
these three compounds were evaluated by comparing the measured amount of endogenous toxins in
non-spiked injections to the measured amount of toxins in the spiked samples. Percent suppression or
enhancement was calculated as µg measured in spiked sample/(µg endogenous toxin + µg toxin added)×100.
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Table 5. Signal enhancement (>100%) and signal suppression (<100%), ± standard deviation, observed
in spiked extracts from triplicate SPATTs deployed in York River, Nassawadox, and Wachapreague
analyzed using final two methods: acidic and basic. Values are reported using the equation: Suppression
or Enhancement (%) = 100 × spiked extract peak area/spiked standard peak area.
Suppression (<100%) or Enhancement (>100%)
York
(%)
Nassawadox
(%)
Wachapreague
(%)
MC-RR 26 ± 1 39 ± 3 38 ± 7
MC-LR 36 ± 0.4 50 ± 2 47 ± 4
MC-YR 32 ± 1 46 ± 2 44 ± 3
AZA1 33 ± 1 33 ± 2 43 ± 12
AZA2 49 ± 3 44 ± 3 52 ± 8
PbTx-2 146 ± 7 109 ± 13 123 ± 5
YTX 103 ± 2 132 ± 10 121 ± 18
DTX2 69 ± 0.8 81 ± 1 78 ± 3
OA * 101 ± 1 103 ± 0.7 101 ± 1
PTX2 * 57 ± 2 45 ± 0.8 36 ± 7
DTX1 * 98 ± 2 96 ± 3 91 ± 1
* calculated by difference due to endogenous phycotoxins present.
Instrumental LODs presented herein (Table 3) were determined using calibration standards, and
as such, toxin-specific matrix effects in SPATT extracts may result in modified limits of detection. More
specifically, phycotoxins that show suppression could be expected to have higher LODs in matrix,
while phycotoxins that show enhancement could result in lower LODs in matrix (Table 5). As presented
here, these methods serve as a screening tool for multiple phycotoxins present in SPATT extracts, part
of an explorative study to determine which phycotoxins are present in Chesapeake Bay. For strictly
quantitative analyses of trace-level concentrations, however, the impact of matrix effects on limits of
detection can be further explored, but matrix effects will likely vary based on season, system, salinity,
and depth of sampling, as typical with estuarine environmental samples, and may also vary based on
injection volume, e.g., 50 µL versus 1000 µL.
3. Conclusions
Two UPLC-MS/MS methods with trap/ACD were developed and optimized to encompass 13
phycotoxins of interest. The use of C18 trapping and analytical columns for both developed methods
allows them to be run sequentially, without an exchange of hardware, resulting in the automated
analysis of a single sample for all 13 phycotoxins. This technology also allows samples to be injected
from solutions in 100% organic solvents, thereby increasing analyte stability and solubility. In practice,
these benefits allow for organic extracts from SPATTs, or other environmental samples, to be injected
directly without the need for dry-down and reconstitution steps, thus streamlining processing by
eliminating hours, or even days, of sample preparation time and avoiding potential evaporative
loss. Additionally, this work demonstrates proof-of-concept for the use of this instrumentation with
high-volume injections. In practice, if results from a 50-µL injection show analyte(s) at or near the
limit of detection/quantification, the sample can easily be rerun using a higher injection volume, up to
1 mL, to increase sensitivity instead of needing to concentrate the analyte(s) through further sample
preparation. These methods were developed for use as a screening tool for the analysis of multiple
marine and freshwater phycotoxins present in a single sample. For a strictly quantitative application
of the developed methods, however, Figure 2 may be used as a reference to choose chromatographic
conditions best suited for the specific suite of target compounds, further reduction of the matrix using
additional sample clean-up steps could also be explored, and additional parent to daughter transitions
could be included for quantification or further confirmation.
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The selected compounds spanned marine and freshwater phycotoxins and a range of
hydrophobicities relevant to Chesapeake Bay and other regions. These methods may be adapted to
include congeners, other phycotoxins with similar polarities, or other classes of bioactive compounds
traditionally analyzed by LC-MS. Figure 2 provides information about peak shape and relative signal
intensity for the tested sets of chromatographic conditions, and can be used as a resource to select
methods best suited for a particular group of phycotoxins. The ability to inject large volumes and screen
for low concentrations of multiple marine and freshwater phycotoxins present in the environment
is beneficial for both research and monitoring purposes. Detecting low concentrations may improve
baseline data, allows for further research into the effects of low-level, chronic exposure, and provides
the potential for early warning when phycotoxin concentrations begin to rise in samples collected for
monitoring purposes. SPATT-based kinetic studies have not yet been completed for all phycotoxins
included in our study. As such, we do not recommend that SPATTs replace more-traditional sampling
methods in support of seafood or drinking water safety regulation, but rather serve as complementary
sampling for monitoring purposes or research. Additionally, the intended use of these analytical
methods is for research purposes; these methods are not recommended for use in regulatory settings
without proper validation and certification.
4. Materials and Methods
4.1. Reagents and Analytical Toxin Standards
All acetonitrile (ACN), methanol (MeOH), isopropyl alcohol (IPA), and acetone (ACT) used
were LC-MS grade (Honeywell Burdick & Jackson, MI, USA). Ultrapure water was prepared using a
Milli-Q system (Millipore, Billerica, MA, USA). Formic Acid Optima LC/MS (Thermo Fisher Scientific,
Waltham, MA, USA), Ammonium Formate Optima LC/MS (Thermo Fisher Scientific, Waltham, MA,
USA), and ammonium hydroxide eluent additive for LC-MS (≥25%, Honeywell Fluka, Charlotte, NC,
USA) were used for mobile phases. Formic Acid 98% (EMD Millipore, Merck, Germany) was used for
the carryover wash solution.
The following biotoxin certified reference materials were purchased from the National Research
Council Canada: azaspiracid-1 (CRM-AZA1-b), azaspiracid-2 (CRM-AZA2-b), dinophysistoxin-1
(CRM-DTX1-b), dinophysistoxin-2 (CRM-DTX2-b), okadaic acid (CRM-OA-d), pectenotoxin-2,
(CRM-PTX2-b), and yessotoxin (CRM-YTX-c). Brevetoxin-2 was purchased from Abcam (ab143469). A
microcystin-RR, -YR, -LR mixed solution was purchased from Sigma Aldrich (33578-1ML). Karlotoxin
3 (KmTx 3) was purified from Karlodinium veneficum by Allen Place (UMCES, Maryland). Goniodomin
A was purified from Alexandrium monilatum by Drs. Constance and Tom Harris [37] and provided by
Dr. Kimberly Reece (VIMS).
4.2. Instrumentation
4.2.1. Mass Spectrometry Conditions
A tandem quadrupole Xevo TQ MS (Waters, Milford, MA, USA) equipped with electrospray
ionization (ESI) was used with multiple reaction monitoring (MRM) for detection. Capillary voltage
was 3.00 kV, desolvation temperature was 450 ◦C, desolvation gas flow was 1100 L/hr, collision gas
flow was 0.15 mL/min, and source temperature was 150 ◦C. The mass spectrometer was operated in
both ESI+ and ESI− modes.
Before chromatography was evaluated, direct infusion experiments were performed on all 13
phycotoxins to optimize cone voltage values for each compound, and collision energy values were
tested by evaluating the production of fragment (daughter) ions (Table 6). A concentrated solution
(50–100 µg/L) of each compound was prepared in methanol. Each solution was individually introduced
into the mass spectrometer through direct infusion. First, composite spectra across 30 MS scans were
assessed for various cone voltage values, starting at 20V and increasing in 10V increments. The
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optimum cone voltage was determined as the cone voltage value that produced the highest molecular
ion signal. Using the optimized cone voltage, composite spectra across 30 MS/MS scans were then
assessed. Starting at 5 eV, collision energy was increased by 5 eV for each consecutive spectrum. From
these spectra, daughter ions, and associated collision energies were evaluated. The collision energy
values that resulted in the highest relative signal for the daughter mass compared to the parent mass
were selected. Once these values were chosen, the exact mass for the daughter ion was chosen by
observing the m/z value corresponding with the apex of the daughter ion peak. Parent > daughter
transitions observed in this study resulted in a small loss of sensitivity due to poor fragmentation. To
compensate for this loss in sensitivity, the parent > parent transition for each compound was used
during method performance characterization, while the dominant parent > daughter transition was
chosen for confirmation (Table 6). All parent > parent transitions were evaluated using a collision
energy of 2 eV to minimize fragmentation.
Table 6. Mass spectrometry parameters for 13 phycotoxins determined through direct infusion
experiments
Analyte IonizationMode Adduct
Molecular
Ion m/z
Cone
Voltage (V)
Dominant
Transition
Detected
Collision
Energy (eV)
MC-RR ESI+ 2H+ 520.0 30 520.0 > 135.1 30
MC-YR ESI+ H+ 1045.5 30 1045.5 > 135.1 85
MC-LR ESI+ H+ 995.5 30 995.5 > 135.1 85
AZA1 ESI+ H+ 842.4 30 842.4 > 824.6 30
AZA2 ESI+ H+ 856.4 30 856.4 > 838.6 30
KmTx 3 ESI+ Na+ 1347.7 70 1347.7 > 937.7 80
GDA ESI+ NH4+ 786.5 30 786.5 > 139.0 40
OA ESI− −H 803.5 30 803.5 > 255.5 60
DTX1 ESI− −H 817.5 30 817.5 > 113.0 70
DTX2 ESI− −H 803.5 30 803.5 > 255.5 60
PTX2 ESI+ NH4+ 876.6 30 876.6 > 841.5 30
YTX ESI− −2H 571.1 30 571.1 > 467.7 30
PbTx-2 ESI+ H+ 895.4 40 895.4 > 877.3 20
All compounds were assessed in both positive and negative ionization modes, and the mode
resulting in the highest signal was chosen (Table 6) for the subsequent chromatography experiments
and evaluation of the final methods. Of the 13 compounds, most were best detected in ESI+ mode,
however, four analytes (OA, DTX1, DTX2, YTX) were best detected by mass spectrometry using ESI−.
Due to the limited availability of purified material, KmTx 3 did not undergo direct infusion, and
literature values were instead used for the purpose of method development [36].
4.2.2. Chromatographic Conditions
For all method development and method evaluation, the UPLC with trap/ACD system (Figure 1)
comprised three binary pumps, one autosampler equipped with a 250 µL loop, and one column
manager. The fluidics were set in a 2-1 trap/elute configuration. Acquity I class binary solvent managers
(Waters, Milford, MA, USA) were used within the UPLC with trap/ACD system: for the loading flow,
ACD, and elution. At-column dilution was applied at a 20:1 ratio of ACD flow rate with the dilutor
stream set to 2 mL/min, and the loading flow rate set to 0.1 mL/min. The elution mobile phase flow was
set to 0.5 mL/min. Loading and diluting phases were prepared with ultrapure water. Acidic loading
and diluting phases were prepared with formic acid, basic with ammonium hydroxide, and neutral
with no additives. Acidic and basic mobile phases were prepared with ACN for the organic (B), and
ultrapure water for the aqueous (A), using the same additives as above. Injection volumes were 50 µL
unless otherwise stated. The sample injection volume was carried by the loading flow, mixed with ACD
flow, and sent to the trapping column. During the first 3 minutes of the 16-min chromatographic run,
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these loading conditions were applied while mobile phase flow was sent through the analytical column
and to the mass spectrometer. This three-minute loading period is necessary for the loading circuit to
empty the 250 µL loop, working in tandem with the diluting circuit to bring the full sample volume
to the trapping column. At 3 min, valve positions were switched so that the mobile phase flowed
through the trapping column before reaching the analytical column. This flow brings analytes to the
analytical column, elutes them off the analytical column, and brings them to the mass spectrometer for
detection. A linear gradient was applied to the mobile phase from 3–8 min, transitioning from 5% B
to 95% B. From 8–9 min, mobile phase composition at 95% B was held constant. From 9–9.5 min, a
linear gradient from 95% B to 5% B was applied, and from 9.5–16 min, the mobile phase flow rate was
dropped to 0.2 mL/min and held at 5% B as wash steps were performed (see Section 4.3.1).
4.3. Development and Optimization
To determine the best chromatographic conditions for the 13 selected compounds, multiple
combinations of trapping columns, analytical columns, and mobile phase solutions were evaluated
using a mixed toxin standard with all 13 phycotoxins prepared in 100% methanol to each be a final
concentration of 5 µg/L. Positive identifications of compounds were established through detection of
the parent mass, confirmatory parent > daughter transitions, and reproducible retention times. Each
peak was qualitatively evaluated for adherence to Gaussian and uniform peak shape. Quantitative
evaluations were performed using signal intensities of peak height, and a color-coded table was
produced providing information about these qualitative and quantitative observations.
To compare the effects of various column chemistries on analyte separation, various trapping
columns and analytical columns were evaluated. Reverse-phase trapping columns (Oasis HLB Direct
Connect HP Column, 2.1 × 30 mm, 20 µm, 80Å; XBridge BEH C18 Direct Connect HP Column, 2.1 ×
30 mm, 10 µm, 130 Å; XBridge BEH C8 Direct Connect HP Column, 2.1 × 30 mm, 10 µm, 130 Å) and
analytical columns (Acquity BEH C18, 2.1 × 50 mm, 1.7 µm, 130 Å; Acquity BEH C8, 2.1 × 50 mm, 1.7
µm, 130 Å) were purchased from Waters (Milford, MA, USA). VanGuard pre-columns matching the
material of the analytical columns were also purchased from Waters.
In addition to traditional mobile phase solutions, UPLC-MS/MS with trap/ACD also utilizes
loading and diluting phases. To determine the optimal conditions for loading, diluting, and mobile
phases, multiple combinations of acidic, basic, and neutral solutions were evaluated for their relative
effects on analyte separation, peak shape, and sensitivity [22]. Combinations (36) of columns, loading
and diluting phases, and mobile phases, were tested. For these combinations, loading and diluting
phases were prepared with 5% additive, and eluting phases were prepared with 0.5% additive.
Once the two best-performing methods were chosen from the 36 conditions, the amount of
additive added to each solution was then varied to optimize conditions and create final methods. Signal
intensities from injections of the same mixed-toxin standard were compared. Percent compositions for
the loading phases were varied from 50 mM (0.2% v/v) to 1330 mM (5% v/v) formic acid for acidic, and
from 6.7 mM (0.1% v/v) to 1300 mM (5% v/v) ammonium hydroxide for basic. For the mobile phases,
acidic additive strengths ranged from 0.2% to 0.5% (v/v), while basic ranged from 0.1% to 0.5% (v/v).
The minimum amount of additive tested for both basic and acidic loading and mobile phases was
adopted from common literature values [19,31,33,38–40]. The addition of ammonium formate (2 mM)
as a buffer to stabilize pH for the acidic solutions was also evaluated.
4.3.1. Carryover Management
Due to the high-volume injections (50–1000 µL), carryover between samples was evaluated and
various wash solutions were tested for their abilities to reduce carryover under the final methods. To
evaluate for carryover, six 50-µL injections of a 100% methanol blank were run after one 50-µL injection
of a 5 µg/L mixed-toxin standard prepared in 100% methanol. Peak areas from the blank run were
compared to peak areas from the standard run. Carryover was calculated as blank peak area/standard
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peak area × 100. Wash steps were prepared using mixtures of acetonitrile, methanol, isopropyl alcohol,
acetone, and formic acid, and the timing and length of the wash steps was varied.
4.4. Method Performance Characteristics
The final methods were validated through a series of steps to confirm repeatability, establish
method detection and quantification limits, determine the linearity range of standard curves, and
confirm positive identification of each compound being evaluated. Parent > parent transitions were
used during method performance characterization. Data generated using parent > parent transitions
were later compared to parent > daughter transitions in SPATT extract (see Section 2.5).
4.4.1. Repeatability
To evaluate repeatability, 7 consecutive injections of an 8 µg/L mixed-toxin standard in 100%
methanol were run. Standard deviations were calculated using the peak areas for each compound.
Percent relative standard deviations (%RSDs) for each compound were calculated as 100 × standard
deviation/average peak area.
4.4.2. Limits of Detection and Quantification
Limits of detection (LODs) were determined at two injection volumes, using two approaches:
mathematically and by reporting the lowest concentration at which the signal to noise ratio (S/N) was
greater than or equal to 3. To determine LODs mathematically, a mixed-toxin standard solution at a
concentration 10× the estimated LOD for each compound was prepared in methanol. Repeated 50-µL
injections (6) from a vial containing this standard were run, and the standard deviations of the peak
areas for each compound were calculated. The LOD peak area for each compound was calculated
as 3.14 × standard deviation, and the LOD concentration was calculated as LOD peak area × sample
concentration/average peak area. Limits of quantification (LOQs) are reported as the lowest concentration
at which S/N was greater than or equal to 10.
LODs were likewise determined for 1000 µL injections. A mixed-toxin standard solution was
prepared in methanol at 10× the estimated LOD for a 1000 µL injection, calculated using the LOD data
from the 50 µL injections. Repeated injections (6) were run, and LODs were calculated as above. A
mixed-toxin standard solution at the estimated LOD for a 1000 µL injection was also prepared, and
triplicate injections were run to confirm S/N ≥ 3.
4.4.3. Linearity
Two standard curves, a low and a high concentration curve, were produced for each compound to
assess linearity across multiple orders of magnitude. A series of 20 dilutions of mixed-toxin standards
were prepared between 0.04 µg/L and 50 µg/L. In triplicate, 50 µL injections were run using the two
methods finalized through method development, and two standard curves were produced to determine
high-concentration and low-concentration ranges of linearity. To confirm linearity, squared correlation
coefficient (R2) values must be >0.99.
4.5. SPATT Analysis
To determine whether the developed methods were acceptable to use as a screening tool for
environmental samples, SPATT passive samplers (SPATTs) were deployed, extracted, and analyzed
for the 13 phycotoxins included in this study using the two final methods. Twelve SPATTs were
constructed using 3.15 g Diaion HP20 resin. In triplicate, SPATTs were deployed in three locations in
the lower Chesapeake Bay region for 2 weeks in April 2018: a tidal river estuary (York River, salinity ca.
22), coastal bayside (Nassawadox, salinity ca. 18), and seaside Eastern Shore (Wachapreague, salinity
ca. 32). Upon recoveries, SPATTs were frozen until extraction. A traditional SPATT extraction method
was employed [23]; in brief, SPATTs were thawed, rinsed with ultrapure water, transferred and packed
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into empty glass solid phase extraction reservoirs, and extracted using 23 mL 100% methanol, (8:1
mL/g resin) at a flow rate no greater than 1 mL/min. Injections, 50 µL, of methanolic SPATT extracts
were analyzed using the developed methods to quantify any endogenous phycotoxins. Results were
normalized to ng toxin per gram SPATT resin per day.
A subsample of each extract was also analyzed after being spiked with a multi-toxin solution
(final concentration of 5 µg/L per phycotoxin) to determine relative signal suppression or enhancement
due to matrix effects. Results from the spiked SPATT extracts were compared to a 5 µg/L multi-toxin
standard in 100% methanol. Possible signal enhancement or suppression, introduced by the sample
matrices, was evaluated using the equation [41] Matrix Effect (%) = 100 × spiked extract peak area/spiked
standard peak area. For extracts in which endogenous compounds were already present before spiking,
percent suppression or enhancement was calculated as µg measured in spiked sample/(µg endogenous
toxin + µg toxin added)×100. KmTx 3 and GDA were not included in the spiking experiment due to the
limited availability of purified material.
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